Proteins can coordinate metal ions with endogenous nitrogen and oxygen ligands through backbone amino and carbonyl groups, but the amino acid side chains coordinating metals do not include tryptophan. Here, we show for the first time the involvement of the tryptophan metabolite kynurenine in a protein metal-binding site. The crystal structure to 1.35Å of MopE* from the methane-oxidizing Methylococcus capsulatus (Bath) provided detailed information about its structure and mononuclear copper-binding site. MopE* contains a novel protein fold of which only one third of the structure displays similarities to other known folds. The geometry around the copper ion is distorted tetrahedral with one oxygen ligand from a water molecule, two histidine imidazoles (His132 and His203) and at the fourth distorted tetrahedral position, the N1 atom of the kynurenine, an oxidation product of Trp130. Trp130 was not oxidized to kynurenine in MopE* heterologously expressed in Escherichia coli, nor did this protein bind copper. Our findings indicate that the modification of tryptophan to kynurenine and its involvement in copper binding is an innate property of M. capsulatus MopE*.
Proteins can coordinate metal ions with endogenous nitrogen and oxygen ligands through backbone amino and carbonyl groups, but the amino acid side chains coordinating metals do not include tryptophan. Here, we show for the first time the involvement of the tryptophan metabolite kynurenine in a protein metal-binding site. The crystal structure to 1.35Å of MopE* from the methane-oxidizing Methylococcus capsulatus (Bath) provided detailed information about its structure and mononuclear copper-binding site. MopE* contains a novel protein fold of which only one third of the structure displays similarities to other known folds. The geometry around the copper ion is distorted tetrahedral with one oxygen ligand from a water molecule, two histidine imidazoles (His132 and His203) and at the fourth distorted tetrahedral position, the N1 atom of the kynurenine, an oxidation product of Trp130. Trp130 was not oxidized to kynurenine in MopE* heterologously expressed in Escherichia coli, nor did this protein bind copper. Our findings indicate that the modification of tryptophan to kynurenine and its involvement in copper binding is an innate property of M. capsulatus MopE*.
Copper is an essential nutrient for all living organisms and molecular systems to maintain adequate supplies of copper have been developed by all cells. Copper-containing proteins play a key role in cellular respiration and are involved in biological processes such as pigment formation, neurotransmitter synthesis, and antioxidant defence. Recently, they have received increasing attention due to their role in human pathogenesis, in particular in neurodegenerative diseases such as Alzheimer, Parkinson and prion diseases (1) .
In Methylococcus capsulatus (Bath) and other methane-oxidizing bacteria, copper is important for both regulation and catalytic activity of the particulate methane-monooxygenase (pMMO) (2) . An equivalent of this enzyme is used by almost all methanotrophs to catalyze the oxidation of methane to methanol, the initial and obligate step for all carbon fixation and energy production in these bacteria. A subset of methanotrophs, including M. capsulatus, produces a second soluble monooxygenase (sMMO). sMMO does not require copper for activity, and is produced only when the level of copper in the growth medium is very low (3, 4) . The pMMO is the most growth effective of the monooxygenases, and hence, copper is required at relatively high levels for methanotrophs to grow optimally (3) . Copper is most likely actively accumulated from the growth medium (3) , and thus the copper-homeostatic activity of methanotrophs differs from that of other prokaryotes in which systems handling extracellular copper is mainly involved in detoxification and elimination (5) .
Both methanobactin and the MopE protein have been postulated to have a role in copper uptake in M. capsulatus (6, 7) . Methanobactin is a small, siderophore-like compound that binds a single copper ion with high affinity (7) . When copper is present in the growth medium, methanobactin is mainly associated with the membranes, possibly in direct association with the pMMO, while at copper-limited growth conditions, methanobactin accumulates in the growth medium. The MopE protein was originally identified as one of five outer membrane associated proteins, designated MopA-E, Mop being short for Methylococcus capsulatus outer membrane protein (8) . Later it was discovered that an N-terminally truncated version (MopE*) of the cell surface associated protein (MopE c ) was secreted in large amounts to the growth medium under copper-limited growth conditions (6, 9) . MopE c is composed of 512 amino acids while MopE* represents the 336 C-terminal amino acids of MopE c . A MopE* homologue, designated CorA, has been isolated from the membranes of the methanotroph Methylomicrobium album BG8 (10) . The expression of both MopE and CorA is negatively regulated by copper, indicating an involvement in copper-homeostatic activities. Importantly, a copper-binding motif could not be predicted with significance from the primary sequence of the two proteins (9, 10) .
In the present study, we determined the crystal structure of MopE* to 1.35 Å resolution, and demonstrate that the protein has a novel protein fold and contains a mononuclear copper site. Importantly, we present evidence that one of amino acids in the copper binding site is kynurenine, a tryptophan derivate not previously described in protein metal-binding sites.
EXPERIMENTAL PROCEDURES
Growth conditions and purification of MopE*. MopE* was obtained from spent medium of M. capsulatus (Bath) strain NCIMB 11132 grown in continuous cultures in NMS medium containing no added copper, as described previously (6), and purified as described in Supplemental information (SI).
Protease treatment and mass spectrometry analyses. MopE* was digested with Lys-C endoproteinase (Roche, Penzberg, Germany). Mass spectrometric analyses (MALDI-TOF MS and MS/MS) were performed at PROBE, University of Bergen. A detailed description is given in Supplemental information.
Metal determination. The amount of copper bound per MopE* molecule was determined by Inductively Coupled Plasma Mass Spectrometry (ICP-MS) at the Center for Element and Isotope Analyses (CEIA), University of Bergen, Norway. See Supplemental information.
The copper binding affinity of MopE. Information on the dissociation constant of copper binding to MopE* was obtained using the Cu(I) chelator Bathocuproine. Bathocuproine disulfonic acid (Sigma) and ascorbate were added to MopE* (∼ 10 µM) in 20 mM Tris-HCl (pH 7.5) and 1 mM CaCl 2 , to final concentrations of 0.5 mM and 1 mM, respectively. Ascorbate was included in the assay to ensure that the Cu ions were maintained in the Cu(I) state. Samples were incubated either at room temperature or at 45 °C for 1 hour with gentle shaking every 5 minutes. The protein was subsequently isolated using a 5 ml Hitrap Desalting column (GE Healthcare), and the concentration of copper in the protein fraction was determined by ICP-MS analyses.
Cloning, expression and purification of MopE* in E.coli. mopE* was amplified by PCR and cloned into the pETM41 vector using BamHI and NcoI restriction sites. Large-scale protein expression was performed using E. coli BL21 StarTM (DE3) and the pETM41 vector. Purification of MopE* is described in Supplemental information.
Crystallization, data collection, structure determination and refinement. All variants of MopE* were crystallized from ammonium sulfate in the pH range 7.0 -7.75. Data were collected at 100 -120 K , and the data were processed in XDS (34), MOSFLM (35) and SCALA and TRUNCATE of the CCP4 suite (36) . The structure was phased by single anomalous dispersion (SAD) techniques using SHELXD (37) on a mercury derivative. The phases were improved by SHARP (38) and solvent flattening using SOLOMON (39) . ARP/wARP (40) was used for automatic tracing of the protein, and the model was further improved by refinement using Refmac5 (41) and manual refitting of the model using O (42) . The structures of MopE* and recombinantly expressed in E. coli (Rec-MopE*) were solved by molecular replacement using MOLREP (43) . A more detailed description of the MopE* structure determination is presented in Supplemental information and data collection and refinement statistics are summarized in Table 1 .
RESULTS
The MopE* structure. Crystals suitable for Xray diffraction studies, with different morphology and cell parameters belonging to monoclinic (C2) and orthorhombic (I222) space groups, were obtained ( Table 1 and Supplemental Fig. S1 ). The crystal structure of MopE* was determined using single anomalous dispersion (SAD) data to 1.9 Å collected on a HgCl 2 derivative (Hg-MopE*). The structures of the wild-type protein (MopE*) and MopE* recombinantly expressed in E. coli (RecMopE*) were determined to 1.35 and 1.65 Å, respectively, by molecular replacement using the mercury derivative as starting model. Data collection and refinement statistics are provided in Table 1 . The three structures of MopE* are essentially similar but with a significant difference in the metal binding site.
The present structure ( Fig. 1) includes the 290 C-terminal residues of the protein, and the structures have been refined to crystallographic Rfactors of about 18 -21% (R work ) and R free of 20 -24% (Table 1) . Main chain atoms of MopE* and Rec-MopE* residues 47 to 336 superimpose on each other with an rmsd value of 0.57Å. The differences are caused by the loops formed by residues 75 -80 (β2 -β3 loop), 105 -110 (β3 -β4 loop), 115 -119 (β4 -β5 loop) and 308 -312 (β19 -β21 loop). Different crystal packing environments in the β2 -β3 and β4 -β5 loops and poorly defined electron density in the solvent exposed β19 -β20 loops of both proteins are expected to cause the different conformations in three of the four loops. Only the conformation of the β3 -β4 loops is expected to be caused by differences in the metal binding sites of the wildtype and recombinant proteins. The 46 N-terminal amino acids of MopE* were not identified in the electron density maps in any of the structures.
The protein forms a nest-like structure with dimensions of about 40 x 45 x 55 Å 3 ( Fig. 1A and C). The majority of the MopE* structure folds into a coiled structure where only a third of the residues forms 21 β-strands (Fig. 1B) . Eight of these build the only extensive secondary structure motif, an antiparallel β-sandwich. The MopE* structure also contains four 3 10 helical segments. The polypeptide is folded such that regions of the N-terminal, the middle, and C-terminal parts all are included in the β-sandwich (Fig. 1) . One of the strands of the sandwich extends into a second 3-stranded sheet such that the central core of the protein is a 6-stranded sheet. Of the remaining β-strands, seven consists of only two residues each, being involved in stabilizing the MopE* structure.
The structure is also stabilized by a calcium ion octahedrally coordinated by three aspartic acid residues (Asp250, Asp252, Asp274), two main chain carbonyl oxygens (Thr276, Ala279) and a solvent molecule (Fig. 1) .
The copper-binding site contains a single partially buried copper ion (Fig. 1C ) located in a trigonal arrangement by the side groups of His132, His203 and, intriguingly, Trp130. Tryptophan has been shown to bind various metals in chemical systems (23, 24) , the indole side chain has not been reported to coordinate metal ions in biological systems. The electron density maps revealed a broken bond between the CD1 and NE1 atoms of Trp130 (Fig. 2 ). In addition, the planar arrangement around the CG atom and the distances from the atom at the CD1 position to the main chain amine nitrogen atoms of residues 130, 131 and 132 suggested oxidation of the tryptophan to kynurenine. Kynurenines are formed by oxidative cleavage of the tryptophan indole ring with subsequent hydrolysis of the CD1 carbon, resulting in a mass increase of 4 Da compared to the unmodified tryptophan (Fig. 3B, SI Fig. S2 ).
The copper ion is also coordinated by an axial water molecule, forming a distorted tetrahedral arrangement of the copper-binding site with the copper ion located almost in the middle of the base of the pyramid and the solvent molecule in the apical position (Fig. 2) . Trigonal, tetrahedral and trigonal bipyramidal are all geometries previously observed for copper binding proteins (25) . The distances between the copper ion and the ND1 atoms of the histidines are in the range 1.99 -2.17 Å, indicating covalent/ionic interactions. This is also in the same order as copper -histidine distances found in most other copper binding proteins (26, 27) . The distance between the copper ion and the nitrogen atom of the kynurenine is about 3 Å, somewhat longer than what is usually considered a copper-nitrogen interaction. The amino group of the kynurenine side chain would generally be considered a poor cooper ligand. The amino group is ca 6 degrees off a linear phenylamino-copper interaction, and as such, does not coincide with a possible amino-metal interaction previously described (25) . The copper to solvent distance in MopE* refines to about 2.5 Å, similar to what is found in other copper proteins. The occupancy of the copper ion is refined to about 0.65, which corresponds well with the ICP-MS analyses on purified MopE* revealing a copper-toprotein ratio between 0.5 and 0.6.
Identification of kynurenine by mass spectrometry. In order to verify the oxidation of tryptophan to kynurenine, purified MopE* was digested with Lys-C and resulting peptides were analyzed by MALDI-TOF mass spectrometry. Computer-generated Lys-C peptide maps of MopE* calculated theoretical m/z ions of 2785 and 2789 for tryptophan and kynurenine, respectively. The MS analyses revealed a MALDI molecular ion at m/z 2789, consistent with the theoretically predicted ion for the kynurenine-containing peptide (Fig. 3A,B (upper panels) ). Subsequent fragmentation of the m/z 2789 ion produced an MS/MS spectrum corresponding to the amino acid sequence Trp112-Lys135 of MopE* (Fig. 3C (left  panel) ). From both the y-ion and b-ion series it was possible to identify a mass increase of 4 Da at residue 130. No distinct peak was observed at m/z 2785 (Fig. 3A,B (upper panels)) .
Analyses of recombinant MopE*. Crystallization and MS studies were also carried out on MopE* heterologously expressed and purified from E. coli (Rec-MopE*). The MS spectrum and MS/MS fragmentation pattern on peptides derived from Rec-MopE* revealed solely the unmodified m/z 2785 peptide, demonstrating that the post-translational formation of kynurenine in MopE* had not occurred when expressed in E. coli (Fig. 3A ,B (lower panels) and 3C (right panel)). This was confirmed by crystal structure analysis of Rec-MopE*. The electron density clearly displayed an intact CD1 -NE1 bond (Fig.  4A ). In addition, the side chain was rotated about 60 degrees in χ1 and 180 degrees in χ2 relative to kynurenine in wild-type MopE* (Fig. 4B) . In order to accommodate the tryptophan side chain in this position, the β3 -β4 loop (residues 105 -110) is displaced about 1.5Å. Thus, the metal binding site is sufficiently disrupted to prevent binding of copper in Rec-MopE*, as demonstrated by the lack of electron density at the wild-type copper position. The latter was confirmed by ICP-MS; Rec-MopE* did not bind detectable levels of copper. These findings substantiate that the conversion of tryptophan to kynurenine is an endogenous modification that specifically takes place in M. capsulatus, and that the oxidation of Trp130 to kynurenine is a prerequisite for copperbinding in wild-type MopE*.
The copper binding affinity of MopE*. Bathocuproine disulfonic acid was used to obtain information on the copper binding affinity of MopE*. Bathocuproine disulfonic acid forms a stable 2:1 complex with Cu(I) with an association constant of ∼10 20 (28) . No significant decrease in the amount of copper bound to MopE* could be observed after treatment with the copper chelator neither at room temperature nor at 45 o C, thus indicating a high affinity binding (K d < 10 -20 M).
DISCUSSION
We here present X-ray diffraction and mass spectrometry data on the M. capsulatus secreted protein, MopE*. The protein presents a unique kynurenine-containing copper-binding site and a novel protein fold, of which only about a third of the MopE* structure displays similarity to known proteins. The only extensive secondary structure element previously observed is an 8-stranded antiparallel β-sandwich formed by about 25% of the residues. This motif is often found in virus capsid proteins and sugar binding and hydrolysing proteins, as well as in oxidoreductases, cupredoxins (proteins with Type I copper centre) and proteins involved in electron transport (DALI database (29) , ProFunc (30) and CATH protein classification database (31)). The remaining residues form an extensive coil-like structure interspersed with 13 short β-strands. Particularly interesting is the copper binding site located in a depression on the molecular surface about 8 -10 Å from the β-sandwich and relatively distant from any secondary structure element. The partially buried copper ion is located between two histidines and an oxidised tryptophan (kynurenine) in a planar trigonal arrangement, and displays therefore similarities to Type I (blue copper proteins) and Cu B copper centres (25, 32) . Type I copper centres are characterized by two histidines and a cysteine in a planar trigonal arrangement and a variable axial ligand. Cu B copper centres coordinate copper by 3 histidines in a trigonal pyramidal geometry and the axial ligand forms a bridge to the Fe-ion of the cytochrome heme. Two and three histidine ligands are frequently observed in copper binding proteins, but to our knowledge, this is the first observation of a tryptophan or a tryptophan metabolite involved in metal binding.
When previously detected in proteins, kynurenine was considered the result of oxidative damage, and in most studies on proteins containing modified tryptophan residues, the kynurenine modification was formed by exposing the proteins to oxidative stress in vitro (33) (34) (35) . There is accumulating evidence that oxidation of specific tryptophan residues is taking place in vivo (36) (37) (38) (39) (40) , but evidence for biological functions of kynurenines in proteins has to our knowledge not been presented. Structural evidence, by NMR, for naturally occuring kynurenine has been provided only for the antibiotic peptide daptomycin (37, 38) from Streptomyces roseosporus. In other studies on kynurenine-containing proteins, kynurenine was detected by MS analyses, and for all proteins examined, the MS spectra revealed two distinct peaks with m/z corresponding to oligopeptides containing both unmodified and modified tryptophan residues (35, 36, 39, 40) . We did not detect the tryptophan-signature peak at m/z 2785 in the mass spectrum of MopE* (Fig. 3A,B ) in our present study. This indicates that oxidation of the specific tryptophan to kynurenine in MopE* is highly efficient in M. capsulatus. The mass increase of 4 Da observed for the modified tryptophan is compatible with an opening of the indole ring resulting in an amino group attached to the phenyl ring and a methyl group at the aliphatic chain (SI Fig. S2C ), but this would not be consistent with the planar arrangement observed around the atom corresponding to the CG position of a Trp130. A methylene group would fit the planar arrangement (SI Fig. S2D ), but this molecule would present a mass increase of 2 Da relative to tryptophan. The relatively short distances from the atom at the possible methyl group corresponding to the Trp130 CD1 position and the main chain nitrogen atoms of residues 131 -133 (2.9 -3.2Å) correspond more to hydrogen bond distances than a polar -nonpolar N -C interaction. Thus, our X-ray diffraction data are consistent with the presence of kynurenine also in the MopE* crystals.
Metal binding distances are generally considered a function of the size, ionization and electron donating properties of the ligand. The distance between the copper ion and the nitrogen atom of the kynurenine is about 3 Å, considerably longer than what is usually considered a coppernitrogen interaction, which is 2 -2.3 Å (see i.e (26, 41) ), and longer than some of the longest Cu -N bonds reported previously (in non-biological systems; 2.8Å (42)). The kynurenine is therefore probably not a first-sphere ligand but the ring amino group is close enough to be a second sphere copper ligand.
The copper content of purified MopE* and crystallized MopE* were similar (0.5-0.6 and 0.65 copper per molecule MopE*, respectively), which was less than what would be expected given the high copper affinity determined for MopE*. Purified MopE* was unable to bind additional copper, added either as Cu + or Cu 2+ (data not shown). The actual copper content of purified MopE* was found by ICP-MS analysis to depend largely on the copper content of the growth medium, but did not exceed about 80% of the sites.
In contrast, when co-crystallizing MopE* (CuMopE*) with 10 mM CuSO 4 , the occupancy of copper increased from from about 65% to 100%. Under copper-containing conditions crystals belonging to a new monoclinic space group (C2; 104.11 x 101.58 x 38.64 Å 3 , β = 101.40
• ) have been obtained. These crystals diffracted to 1.6 Å, (data not shown). The addition of copper to the crystallization conditions had only minor effects on the binding distances, with differences to the neighbouring amino acids less than 0.1 Å. The copper-binding site is open to the solvent in both crystal forms, and should in principle not be significantly influenced by close crystal packing interactions. The differences are in the same order as the coordinate error (0.06 Å -0.08 Å), and hence, no trend related to copper occupancy could be drawn.
A possible explanation for the difference in metal binding capacity between purified (65%) and crystallized MopE* (65-100%) could be related to structural differences, and may to some degree reflect the amount of copper bound during expression and retained through purification. In the crystal, the 46 N-terminal amino acids are invisible in the electron density maps in all crystal forms, suggesting that this domain is unstructured or cleaved off during the crystallization process. We hypothesize that in solution, the N-terminal domain of MopE* may serve as a lid regulating/inhibiting further metal binding. Removal of this domain would expose the binding site to the solvent, allowing copper binding in all sites.
The kynurenine amino group is ca 6 degrees off a linear phenyl-amino-copper interaction and as such, does not fit the amino-metal interaction requirements described by Holm and collaborators (25) . The kynurenine residue is therefore apparently not a ligand in the classical sense and at present we can only speculate about the function of kynurenine in the copper binding site of MopE*. Since the Trp130 of MopE* expressed in E. coli is not oxidized and this protein does not bind copper neither in solution nor in crystals grown in the presence of copper, it is likely that the conformational changes that take place as a consequence of Trp130 oxidation to kynurenine is a requisite for Cu binding. The solvent exposed indole side chain of Trp130 in Rec-MopE* is stabilised only by a hydrogen bond to Asp105 and by weak hydrophobic interactions to neighbouring residues. After oxidation, rotation of the kynurenine side chain allows stabilization of the carbonyl oxygen through hydrogen bonds to the main chain amine nitrogen atoms of residues 131 -133. Kynurenine in this conformation reduces the size and flexibility of the otherwise relatively open copper binding site, possibly providing a structural pocket for entrapment of the copper ion and thus ensuring efficient covalent/ionic binding to the histidine ligands.
The chemical properties of Trp are considered incompatible with direct metal-coordination in biological systems (24) . Consistent with this, the E. coli expressed Rec-MopE* containing only unmodified Trp130, did not bind detectable levels of copper. The lack of Trp modification in RecMopE* is intriguing because it suggests that this modification is enzymatically mediated, and consequently most likely requires other protein(s) to catalyse the reaction. In this respect, it is interesting that the mopE gene (MCA2589) is located in an operon with the MCA2590 gene encoding a protein displaying sequence similarity to the tryptophan-modifying MauG proteins (6, 43) . The MauG proteins are c-type cytochromes which are required for biosynthesis of tryptophan tryptophylquinone, the prosthetic group of methylamine dehydrogenase (44, 45) . The M. capsulatus MauG homologue is, like MopE*, located on the surface of the bacterium and is a member of a novel group of the bacterial di-heme cytochrome c peroxidase family with unknown function (43) . The MCA2590 encoded cytochrome may be active in the conversion of Trp130 to kynurenine, but this possibility remains to be investigated. Interestingly, a protein with 50% sequence similarity to the M. capsulatus MCA2590 encoded cythochrome is predicted from an unannotated ORF located immediately downstream of CorA, the MopE* homologue produced by the methanotroph M. microbium BG8 ((10) see below).
The structure of MopE* displays little resemblance to known copper proteins, and the function can therefore not be predicted from the structure. To date, the copper-repressible CorA protein is the only known MopE homologue. CorA is composed of 204 amino acids, all of which can be aligned to the C-terminal region (aa 56 to 336) of MopE* (9) and with conserved residues around the metal binding sites (SI Fig. S3 ). Also the three aspartic acid residues that contribute side chain coordinates for the calsium ion in MopE* (Fig. 1,  SI Fig. S3 ) are conserved in CorA. Thus, circumstantial evidence indicates that MopE and CorA have a related function in copperhomeostatic activities. Since MopE is copperrepressed and has a very high affinity for copper, it is tempting to speculate that MopE plays a role in copper uptake and transport at low copper culture conditions. Very little information about copper uptake in methanotrophs is available. The only molecule, in addition to MopE, that has been linked to copper transport in these bacteria is methanobactin (7) . Like MopE*, methanobactin is accumulated in the medium at low-copper growth conditions and binds a single copper with high affinity, similarly to MopE*. A low K d would be expected for a copper-binding protein operating in a low-copper environment. If MopE is involved in copper transport, a copper-receptor is likely to exist at the cellular surface, but candidate molecules mediating intracellular transport remains to be identified and characterisation of MopE participation in copper-homeostasis must await further studies.
The finding of kynurenine as oxidized tryptophan residues in biological systems has so far been described from studies related to oxidative stress or exposure to reactive oxygen species (33) (34) (35) (36) (37) (38) (39) (40) . In the case of E. coli expressed MopE*, Trp130 was not oxidized to kynurenine when exposed to strong oxidizing conditions. This could indicate that the oxidation of Trp130 in M. capsulatus is enzymatically catalysed. If so, it is tempting to speculate that MopE* is involved in a redox process important for the uptake of copper ions, which most likely takes place at the surface of the bacterium. Involvement in a transport process would explain the reason for choosing a weak ligand, such as kynurenine, because easier transfer of the copper ion to its receptor molecule would be anticipated. The receptor molecule would still have to induce chemical and/or conformational changes to MopE* in order to release the copper ion. Experiments are initiated to elucidate these questions, and unravel whether the role of kynurenine in copper-binding is a unique trait of MopE, restricted to proteins of methaneoxidizing bacteria, or whether it is a more frequent structural feature in biological metal coordination.
The identification of the kynurenine reported here is an important observation of a structural difference between a wild-type protein and its heterologously expressed counterpart. It thus provides a warning example that a heterologously expressed protein does not always exert the same properties as that from the wild-type organism. In the case of MopE, the modification takes place only when endogenously expressed in M. capsulatus, and thus appears to be linked to its biological function. In this case, the general use of recombinant proteins for structure studies may have made the detection of the kynurenine elusive.
The atomic coordinates and structure factors (code 2VOV, 2VOW and 2VOX) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/). Fig. 1. A) Ribbon diagram illustrating the fold of the MopE* structure. The β-strands forming the secondary structure elements of MopE* are labeled B1 through B21 and the coloring follows the topology diagram described below. Copper is represented as a yellow sphere located between His132, His203, Kynurenine130, and a water molecule (red sphere) in a tetrahedral arrangement. A single calcium ion (green sphere) is coordinated by the side chains of Asps 250, 252, 274, and the main chain carbonyl oxygen of Thr276 and Ala279. B) Topology diagram (generated at http://www.tops.leeds.ac.uk/) illustrating the organization of secondary structure elements of MopE*. Triangles represent β-strands and circles represent 3 10 -helical segments. Blue triangles represent the β-sandwich and cyan triangles represent the additional strands forming the central core. Red triangles represent strands consisting of only two amino acids. C) Transparent van der Waals surface, including ribbon representation, illustrating the crystal structure of MopE*. The ribbon is rainbow colored where blue is at the N-terminal of the structure and red at the C-terminal. Copper is represented as a yellow sphere and calcium as a green sphere. 
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